NCT07288905

Brief Summary

Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in healthy and CKD patients

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
57mo left

Started Oct 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Oct 2025Dec 2030

Study Start

First participant enrolled

October 4, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

November 16, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 17, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

December 17, 2025

Status Verified

December 1, 2025

Enrollment Period

2.2 years

First QC Date

November 16, 2025

Last Update Submit

December 3, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Diaphragm excursion and thickness

    Diaphragm excursion (unit: mm) and thickness (unit: mm) are examined by diaphragmatic ultrasound when a participant performs maximal inspiration and expiration

    Change from baseline (0 week) to follow up (16 weeks)

  • Exercise capacity

    A cardiopulmonary exercise test collects gases (including measures of oxygen consumption in ml/kg/min), which can be used to estimate exercise capacity

    Change form baseline (0 week) to follow up (16 weeks)

Secondary Outcomes (18)

  • Heart rate variability (Standard Deviation of Normal-to-Normal Intervals, SDNN)

    Change form baseline (0 week) to follow up (16 weeks)

  • Heart rate variability (Root Mean Square of Successive Differences, RMSSD)

    Change form baseline (0 week) to follow up (16 weeks)

  • Heart rate variability (Low Frequency power, LF)

    Change form baseline (0 week) to follow up (16 weeks)

  • Heart rate variability (High Frequency power, HF)

    Change from baseline (0 week) to follow-up (16 weeks)

  • Heart rate variability (LF/HF Ratio)

    Change from baseline (0 week) to follow-up (16 weeks)

  • +13 more secondary outcomes

Study Arms (4)

healthy

EXPERIMENTAL

We will provide BFR combined with exercise

Behavioral: Aerobic exerciseBehavioral: Blood flow restrictionBehavioral: Resistance exerciseBehavioral: Disease and exercise suggestion

CKD usual care group

ACTIVE COMPARATOR

We will provide patient education, home-based moderate to low-intensity rehabilitation

Behavioral: Disease and exercise suggestion

CKD traditional rehabilitation group

ACTIVE COMPARATOR

We will provide aerobic exercise, resistance exercise training, and patient education

Behavioral: Aerobic exerciseBehavioral: Resistance exerciseBehavioral: Disease and exercise suggestion

CKD BFR group

EXPERIMENTAL

We will provide BFR combined with exercise and patient education

Behavioral: Aerobic exerciseBehavioral: Blood flow restrictionBehavioral: Resistance exercise

Interventions

The aerobic exercise intervention will utilize stationary bike. The program will be conducted 2 times per week over a 12 weeks

CKD BFR groupCKD traditional rehabilitation grouphealthy

Blood flow restriction intervention will combined aerobic exercise and resistance exercise. The program will be conducted 2 times per week over a 12 weeks

CKD BFR grouphealthy

The resistance exercise will bilateral leg extension. The program will be conducted 2 times per week over a 12 weeks

CKD BFR groupCKD traditional rehabilitation grouphealthy

The participants will received self-care technique and home-based exercise approach

CKD traditional rehabilitation groupCKD usual care grouphealthy

Eligibility Criteria

Age20 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 20\~85 years old

You may not qualify if:

  • Severe uncontrolled metabolic diseases (e.g., hyperthyroidism, diabetes, hypertension, hyperlipidemia, etc.)
  • Severe pulmonary or cardiovascular diseases (e.g., pulmonary hypertension, chronic obstructive pulmonary disease (COPD), heart failure, cardiac arrhythmia)
  • Presence of a cardiac pacemaker or a history of myocardial infarction within the past six months
  • Severe musculoskeletal or neuromuscular disorders (e.g., advanced arthritis, limb amputation, post-polio syndrome, Parkinson's disease)
  • Unstable vital signs (e.g., systolic blood pressure ≥180 mmHg, diastolic blood pressure ≥90 mmHg, requiring vasopressors, or resting heart rate \>100 bpm)
  • Prone to bruising
  • Recent inflection \< 1 month
  • Pregnancy
  • Kidney function impairment
  • Cancer
  • Simultaneously participating in other research
  • CKD
  • Aged 20\~85 years old
  • eGFR\< 90 ml/min/1.73 m2 over 3 months
  • Stable condition without worsening in the past 3 months
  • +9 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng Kung University Hospital

Tainan, 701, Taiwan

RECRUITING

MeSH Terms

Conditions

Renal Insufficiency, Chronic

Interventions

ExerciseBlood Flow Restriction TherapyResistance Training

Condition Hierarchy (Ancestors)

Renal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, Human

Study Officials

  • Kun-Ling Tasi, PhD

    Department of Physical Therapy, National Cheng Kung University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair, Department of Physical Therapy

Study Record Dates

First Submitted

November 16, 2025

First Posted

December 17, 2025

Study Start

October 4, 2025

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2030

Last Updated

December 17, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

IPD sharing plan will be decided after summarized data being published

Locations